Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter. Copyright ©2013. No articles may be reproduced without written permission of the publisher.

Archives

FDA-Approved ADHD Drugs Found Beneficial And Safe, But Safety Of A New ADHD Drug Questioned

Eyecare Update #2

FDA Panel Recommends Tysabri Return to the Market for Multiple Sclerosis

FDA Softens Warnings About the Safety of Birth Control Patches

Anti-Infective Drugs Advisory Committee Recommends Label Expansion for Cubist Pharmaceuticals' Cubicin (Daptomycin)

Healthcare Information and Management Systems Society (HIMSS)

Cardiac Surgery Update

Hospice Update

Healthcare IT

Eyecare Update

Vagus Nerve Stimulation for Treatment-Resistant Depression

LASIK Update

Neurology Update

Vagus Nerve Stimulation for Treatment-Resistant Depression

San Antonio Breast Cancer Symposium (SABCS)

Search

Events Calendar

Categories

Get Adobe Reader

Disclaimer